<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00906438</url>
  </required_header>
  <id_info>
    <org_study_id>2006-RD-05-CLN1</org_study_id>
    <nct_id>NCT00906438</nct_id>
  </id_info>
  <brief_title>Effects of 2006-RD-05 on Salivary and Serum Immunoglobulin A (IgA) Levels in Healthy Subjects</brief_title>
  <official_title>Effects of 2006-RD-05 on Salivary and Serum IgA Levels in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>innoVactiv Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>innoVactiv Inc.</source>
  <brief_summary>
    <textblock>
      It is already known from animal studies that the study drug can improve mucosal immunity as
      shown by increased serum and mucosal IgA secretion. This study will evaluate the safety of an
      oral intake of the natural product 2006-RD-05 at the recommended daily dose of 300 mg. In
      addition, this trial will aim to determine if this intake is able ot improve serum and
      salivary IgA synthesis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of adverse events</measure>
    <time_frame>Baseline, 14 days, 28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum IgA titers</measure>
    <time_frame>Baseline, 14 days, 28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Salivary IgA titers</measure>
    <time_frame>Baseline, 14 days, 28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Treated</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>2006-RD-05</intervention_name>
    <description>300 mg daily, once a day for 28 consecutive days</description>
    <arm_group_label>Treated</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Capsule similar in shape, weight and color from active, once a day for 28 consecutive days</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men or women aged 18 - 60

          -  In good health

          -  BMI between 20 and 30 kg/m2

          -  Non-smoking

        Exclusion Criteria:

          -  Allergic to study drug

          -  Use of immune-modulating drugs

          -  Uncontrolled hypertension (Systolic &gt; 140 or diastolic &gt; 90)

          -  Women of childbearing age not using proper contraception, that is pregnant or
             breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institut des Nutraceutiques et des Aliments Fonctionnels (INAF)</name>
      <address>
        <city>Quebec</city>
        <zip>G1K 7P4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 20, 2009</study_first_submitted>
  <study_first_submitted_qc>May 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2009</study_first_posted>
  <last_update_submitted>October 28, 2009</last_update_submitted>
  <last_update_submitted_qc>October 28, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2009</last_update_posted>
  <responsible_party>
    <name_title>Scientific Director, Health &amp; Nutrition</name_title>
    <organization>innoVactiv inc.</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

